Results 61 to 70 of about 627 (174)

CLINICAL SCIENCES Glutathione and Glutathione S-Transferases as Early Markers for Ovarian Carcinomas: Case Series [PDF]

, 2001
Aim. To determine the activity of glutathione (GSH) and concentrations of glutathione S-transferases (GST), urokinase type plasminogen activator (uPA), and plasminogen activator inhibitor type 1 (PAI-1), and to evaluate their diagnostic and prognostic ...
Andreja Ambrioviae Ristov, Damir Babiae, Dr´islav Kalafatiae, Duško Milièiae, Ivan Vrhovec, Janez Škrk, Maja Osmak, Marija Abramiae, Marina Šprem   +8 more
core  

Acute aortic occlusion after microendoscopic laminectomy in a patient with lumbar spinal stenosis: A case report. [PDF]

Medicine (Baltimore), 2021
Inoue H, Sugaya A, Kimura Y, Shiraishi Y, Sugawara R, Kimura A, Takeshita K.   +6 more
europepmc   +1 more source

Suprachoroidal haemorrhage (SCH) drainage using suprachoroidal tissue plasminogen activator (t-PA) after complicated cataract extraction (two-staged procedure): early intervention could mean better vision. [PDF]

BMJ Case Rep, 2021
Akram H, Dowlut MS, Chandra A.
europepmc   +1 more source

MS [PDF]

, 2007
thesisMany haemorrhagic complications have been attributed to increased intravascular fibrinolytic activity. The degradation products resulting from fibrinolysis have been shown to interfere in fibrin polymerization and have been observed in defective ...
Maxwell, Molly Tucker
core  

The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000
Single-chain urokinase-type plasminogen activator (scu-PA) is cleaved by thrombin, resulting in an inactive molecule called thrombin-cleaved two-chain urokinase-type plasminogen activator (tcu-PA/T). There is no knowledge about cell-mediated inactivation of scu-PA. We have studied whether scu-PA bound to cultured human umbilical vein endothelial cells (
Braat, E.A.M., Collen, A., Jie, A.F.H., Grimbergen, J.M., Rijken, D.C.   +4 more
openaire   +3 more sources

Angiotensin-Converting Enzyme Inhibitors and Other Medications Associated With Angioedema. [PDF]

Cureus, 2023
Landry L, Witten T, Anwar AI, Jackson CN, Talbot NC, Ahmadzadeh S, Varrassi G, Shekoohi S, Kaye AD.   +8 more
europepmc   +1 more source

Effects of Epsilon-Amino-Caproic Acid on Prolactin-Inactivating and Fibrinolytic Activities of Streptokinase-Activated Plasminogen.

Experimental Biology and Medicine, 1963
SummaryOvine prolactin (0.5 mg) was incubated for 2 hours at 37.5°C with human plasminogen with and without e-aminocaproic acid (EACA). Fibrinolytic activity (FA) and prolactin-inactivating activity (PIA) were increased by streptokinase (SK). EACA at 0.026 M (5.0 mg) and 0.26 M (50.0 mg) increased FA but did not increase PIA.
T F, HOPKINS, J, MEITES
openaire   +2 more sources

The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease. [PDF]

Thromb Haemost, 2023
Nilsen DWT, Røysland M, Ueland T, Aukrust P, Michelsen AE, Staines H, Barvik S, Kontny F, Nordrehaug JE, Bonarjee VVS.   +9 more
europepmc   +1 more source

Prion diseases: actual clinical and diagnostic aspects [PDF]

, 2018
Prion diseases constitute a very specific group of neurodegenerative disorders. Despite many years of studies, little avail was achieved in terms of effective treatment.
Akimova, P. O., Autlev, M. K., Kozlov, M. V., Kruchinin, E. V., Kuznetsov, V. V., Lukashonok, A. S., Mokin, E. A., Sominov, A. B., Акимова, П. О., Аутлев, М. К., Козлов, М. В., Кручинин, Е. В., Кузнецов, В. В., Лукашенок, А. С., Мокин, Е. А., Соминов, А. Б.   +15 more
core  

Dual mutation (MTHFR A1298C with PAI (4G) mutation) manifesting with bilateral lower limb gangrene in a neonate. [PDF]

BMJ Case Rep, 2021
Kumar A, Ramachandran S, Swain P, Negi V.   +3 more
europepmc   +1 more source